Vanguard Therapeutics, Inc.

Half Moon Bay, CA

UEI
W27EZJ6JUGH3
CAGE
5XT35
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Veteran Owned Business
  • Manufacturer of Goods
  • American Indian Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
108 Eagle Trace Dr, Half Moon Bay, CA 94019, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Improved oral p-selectin blocker for prophylactic sickle cell disease therapy R44HL136117 National Institutes of Health $0
Improved oral p-selectin blocker for prophylactic sickle cell disease therapy R43HL123059 National Institutes of Health $226,033
Improved oral p-selectin blocker for prophylactic sickle cell disease therapy R44HL123059 National Heart Lung and Blood Institute (NIH) $1,992,124
Reliable assays for pentosan polysulfate sodium R43HL118788 National Institutes of Health $335,702

Quick answers

Is Vanguard Therapeutics, Inc. registered in SAM.gov?

Yes. Vanguard Therapeutics, Inc.'s SAM.gov registration is active through February 5, 2027.

What is Vanguard Therapeutics, Inc.'s most recent federal award?

Vanguard Therapeutics, Inc.'s most recent federal grant award is Improved oral p-selectin blocker for prophylactic sickle cell disease therapy (R44HL136117), from National Institutes of Health, on September 21, 2017.

On GovTribe

See Vanguard Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login